The Fat Science team is back with more information on metabolic meds! Dr. Emily Cooper, Andrea Taylor, and Mark Wright explore the impact of GLP-1 medications on appetite and weight loss.

Dr. Cooper examines how these drugs, initially for diabetes, improve metabolic health by addressing appetite regulation and natural hormone balance. Andrea and Mark share their transformative experiences with GLP-1 medications, noting reduced appetite and healthier eating habits. The hosts stress the importance of long-term health over short-term weight loss, offering strategies to minimize side effects and maximize benefits.

Key Takeaways:

-GLP-1 medications address metabolic dysfunction and improve appetite regulation.

-These medications often work better without prior calorie-restrictive diets.

-Personalized dosing prevents side effects.

-Mechanical eating with balanced meals and consistent intervals is crucial.

-GLP-1 drugs were originally for diabetes but have significant weight loss benefits.

Resources from the episode:

Learn more about Fat Science here.
Connect with Dr. Emily Cooper on LinkedIn.
Connect with Andrea Taylor on LinkedIn.
Connect with Mark Wright on LinkedIn.

Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go (and stay!) away. In each episode, we share little-known facts and personal experiences to dispel misconceptions, reduce stigma, and instill hope. Fat Science is committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

If you have a show idea, feedback, or just want to connect, email Mark Wright at mark@beatsworking.show.

Börsepeople im Podcast S17/01: Andrea Benckendorff